Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYellow Cake Regulatory News (YCA)

Share Price Information for Yellow Cake (YCA)

Share Price is delayed by 15 minutes
Get Live Data
545.00    -5.00 (-0.91%)
Bid:
543.50
Ask:
545.00
Spread: 1.50 (0.276%)
Market Cap: £1.37b
YCA Live PriceLast checked at - London Stock Exchange

Intraday Yellow Cake Share Chart

Statement regarding Shareholder Consultation

28 Feb 2025 07:01

RNS Number : 7705Y
Yellow Cake PLC
28 February 2025
 

28 February 2025

Yellow Cake plc ("Yellow Cake" or the "Company")

Statement regarding Shareholder Consultation

 

Yellow Cake, a specialist company operating in the uranium sector holding physical uranium ("U3O8") for the long term, provides an update, in accordance with the UK Corporate Governance Code following its Annual General Meeting held on 3 September 2024 ("AGM").

While all resolutions were passed by a majority of shareholders, Resolution 5 (re-appointment of Sofia Bianchi) and Resolution 11 (an advisory resolution to approve the directors' remuneration report) were passed with the necessary majority but received less than 80% of votes in favour.

At the time of the AGM announcement, the Company noted that Investor Shareholder Services ("ISS"), a proxy advisory firm, recommended that shareholders vote against Sofia Bianchi's re-appointment on 21 August 2024 on the basis of the number of Ms Bianchi's other board positions. On 30 August 2024, following clarification that two of Ms Bianchi's board appointments were within the same shareholder group, ISS recommended that shareholders vote in favour of her re-appointment. Given that the amended ISS recommendation was issued shortly before the proxy voting deadline, there may have been insufficient time for shareholders who follow these recommendations to amend their votes.

ISS also recommended that shareholders vote against the directors' remuneration report, stating that the vesting of Long-Term Incentive Plan ("LTIP") awards was not conditional on the achievement of performance conditions. While the Company did not consider ISS' analysis of the LTIP scheme to be fair or accurate, it undertook to consult with those shareholders who voted against this resolution to better understand their specific concerns.

In light of the feedback received from shareholders and ISS, the Remuneration Committee (the "Committee") has taken the opportunity to review and amend the LTIP with advice from an independent remuneration consultant, to ensure improved alignment with the shareholder experience and expectations (the "Updated LTIP"). The Committee proposes to replace the market-value options with Performance Shares. Performance Shares are a simple and transparent structure and are well-understood by our shareholders and proxy advisors. The Updated LTIP also directly addresses ISS's concerns around performance conditions. The performance conditions have been selected to better align management with investors seeking to participate in an expected increase in the uranium price.

The Company consulted with major shareholders following the LTIP re-design and is therefore confident that the design of this Updated LTIP appropriately rewards management, aligns their interests with those of our shareholders, and ensures that there is no reward for poor performance. The grant of LTIP awards in respect of the financial year ending 31 March 2025 would normally be granted at the start of the financial year, but was deferred pending shareholder consultation. These awards were instead granted on 27 February 2025 and reflect the terms of the Updated LTIP, a summary of which was provided in Yellow Cake's separate regulatory announcement, 'Grant of Awards Under Long Term Incentive Plan', published on 28 February 2025. The new directors' remuneration policy will be fully detailed in the Company's 2025 Annual Report.

The Company will continue to engage with its shareholders on remuneration related matters.

Enquiries:

 

Yellow Cake plc

Andre Liebenberg, CEO

Carole Whittall, CFO

+44 (0) 153 488 5200

Nominated Adviser and Joint Broker:

Canaccord Genuity Limited

James Asensio

Henry Fitzgerald-O'Connor

Charlie Hammond

+ 44 (0) 207 523 8000

Joint Broker: Berenberg

Matthew Armitt

Jennifer Lee

Detlir Elezi

Tel: +44 (0) 203 207 7800

Financial Adviser: Bacchus Capital Advisers

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

Communications Adviser: Sodali & Co

Peter Ogden

+44 (0) 779 385 8211

 

 

 

ABOUT YELLOW CAKE

Yellow Cake is a London-quoted company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 21.68 million lb of U3O8, all of which is held in storage in Canada and France. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRTRMFTMTTTBPA
Date   Source Headline
2nd Aug 20217:00 amRNSQUARTERLY OPERATING UPDATE
26th Jul 20217:01 amRNSGrant and Exercise of Share Options
26th Jul 20217:00 amRNSPublication of Annual Report and AGM Notice
19th Jul 20217:00 amRNSAnnual Results for the year ended 31 March 2021
24th Jun 202112:45 pmRNSTR-1: Notification of major holdings - Replacement
24th Jun 20217:00 amRNSTR-1: Notification of major holdings
17th Jun 20217:07 amRNSResults of Placing and Retail Offer
16th Jun 20214:37 pmRNSRetail Offer
16th Jun 20214:35 pmRNSProposed Uranium Purchase, Placing, Retail Offer
10th Jun 202110:30 amRNSResults of 2021 General Meeting
8th Jun 20214:10 pmRNSTR-1: Notification of major holdings
25th May 20217:00 amRNSNotice of General Meeting
11th May 20217:00 amRNSPurchase of Additional Uranium
28th Apr 202111:48 amRNSTR-1: Notification of major holdings
20th Apr 20217:00 amRNSQUARTERLY OPERATING UPDATE
1st Apr 20217:00 amRNSBoard Change
30th Mar 202112:29 pmRNSExercise of Option by Uranium Royalty Corp.
15th Mar 20217:00 amRNSExercise of Option, Purchase of Additional Uranium
8th Mar 20217:00 amRNSNotification of Major Holdings
8th Mar 20217:00 amRNSNotification of Major Holdings
5th Mar 20213:07 pmRNSNotification of Major Holdings
5th Mar 20213:04 pmRNSNotification of Major Holdings
4th Mar 20217:00 amRNSNotification of Major Holdings
26th Feb 20217:00 amRNSResults of Placing and Retail Offer
25th Feb 20216:20 pmRNSProposed Uranium Purchase,Placing,Retail Offer-Amd
25th Feb 20215:18 pmRNSRETAIL OFFER VIA PRIMARYBID.COM
25th Feb 20215:12 pmRNSLAUNCH ANNOUNCEMENT
25th Jan 20217:00 amRNSQuarterly Operating Update
22nd Dec 20206:26 pmRNSNotification of Major Holdings
10th Dec 20207:00 amRNSVariation of long-term Incentive Share Options
10th Dec 20207:00 amRNSInterim Financial Report
3rd Dec 20208:39 amRNSNotification of Major Holdings
12th Nov 20201:05 pmRNSPresentation to Shares Investor Evening
3rd Nov 20207:00 amRNSCompletion of Buyback Programme
2nd Nov 20207:00 amRNSTransaction in Own Shares
30th Oct 20207:00 amRNSTransaction in Own Shares
29th Oct 20207:00 amRNSTransaction in Own Shares
28th Oct 20207:00 amRNSTransaction in Own Shares
27th Oct 20207:00 amRNSTransaction in Own Shares
26th Oct 202011:01 amRNSNotification of Major Holdings
26th Oct 20207:00 amRNSTransaction in Own Shares
23rd Oct 20207:00 amRNSTransaction in Own Shares
22nd Oct 202011:39 amRNSNotification of Major Shareholding
22nd Oct 20207:48 amRNSTransaction in Own Shares
21st Oct 20207:00 amRNSQuarterly Trading Update
21st Oct 20207:00 amRNSTransaction in Own Shares
20th Oct 20207:00 amRNSTransaction in Own Shares
19th Oct 20207:00 amRNSTransaction in Own Shares
16th Oct 20207:00 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.